PSMD14
26S proteasome non-ATPase regulatory subunit 14
Also known as: pad1, POH1, PSDE_HUMAN, Rpn11
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00487
- Gene
- PSMD14
- Ensembl
- ENSG00000115233
- Chromosome
- 2
- Canonical length
- 310 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a component of the 26S proteasome. The 26S proteasome is a large multiprotein complex that catalyzes the degradation of ubiquitinated intracellular proteins. The encoded protein is a component of the 19S regulatory cap complex of the 26S proteasome and mediates substrate deubiquitination. A pseudogene of this gene is also located on the long arm of chromosome 2. [provided by RefSeq, Feb 2012]
Canonical amino-acid sequenceUniProt
310 residues, UniProt reviewed canonical sequence.
>O00487|PSMD14
1 MDRLLRLGGG MPGLGQGPPT DAPAVDTAEQ VYISSLALLK MLKHGRAGVP MEVMGLMLGE
61 FVDDYTVRVI DVFAMPQSGT GVSVEAVDPV FQAKMLDMLK QTGRPEMVVG WYHSHPGFGC
121 WLSGVDINTQ QSFEALSERA VAVVVDPIQS VKGKVVIDAF RLINANMMVL GHEPRQTTSN
181 LGHLNKPSIQ ALIHGLNRHY YSITINYRKN ELEQKMLLNL HKKSWMEGLT LQDYSEHCKH
241 NESVVKEMLE LAKNYNKAVE EEDKMTPEQL AIKNVGKQDP KRHLEEHVDV LMTSNIVQCL
301 AAMLDTVVFKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSMD14 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 119 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 119 nTPM
- tongue: 71 nTPM
- tonsil: 49 nTPM
- spinal cord: 48 nTPM
- parathyroid gland: 48 nTPM
- cerebral cortex: 47 nTPM
Single-cell type
- syncytiotrophoblasts: 286 nCPM
- esophageal apical cells: 207 nCPM
- cytotrophoblasts: 205 nCPM
- late primary spermatocytes: 200 nCPM
- extravillous trophoblasts: 196 nCPM
- endometrial glandular cells: 179 nCPM
Immune cell
- T-reg: 84 nTPM
- myeloid DC: 75 nTPM
- plasmacytoid DC: 75 nTPM
- total PBMC: 73 nTPM
- memory CD8 T-cell: 71 nTPM
- NK-cell: 70 nTPM
Brain region
- white matter: 45 nTPM
- spinal cord: 40 nTPM
- pons: 40 nTPM
- hypothalamus: 38 nTPM
- cerebral cortex: 37 nTPM
- medulla oblongata: 36 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.3
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 3.57
- DepMap mean gene effect
- -1.64
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- double-strand break repair via homologous recombination
- double-strand break repair via nonhomologous end joining
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein deubiquitination
- protein K63-linked deubiquitination
- regulation of proteasomal protein catabolic process
- response to ethanol
- ubiquitin-dependent protein catabolic process
Molecular functions
- endopeptidase activator activity
- K63-linked deubiquitinase activity
- metal ion binding
- metal-dependent deubiquitinase activity
- metallopeptidase activity
- proteasome binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- JAB1/MPN/MOV34 metalloenzyme domain
- MPN domain
- JAMM/MPN+ metalloenzymes, peptidase M67A
- JAB1/Mov34/MPN/PAD-1 ubiquitin protease
- 26S proteasome regulatory subunit RPN11, C-terminal domain
- 26S proteasome regulatory subunit RPN11 C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PSMD14 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSMD14 as an antibody target. Whether an autoantibody or antibody against PSMD14 could matter depends on whether native PSMD14 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSMD14 is annotated as secreted, so native PSMD14 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PSMD14 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...